Publications by authors named "Masoud Azizad"

Claim this Profile
A
A phase 3 randomized, double-blind clinical study to evaluate the safety and immunogenicity of V116 when administered concomitantly with influenza vaccine in adults 50 years of age or older.
Tosin Omole, Aaron S Weinberg, Masoud Azizad, David Greenberg, Carlos G Grijalva

Vaccine· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Plozasiran, an RNA Interference Agent Targeting APOC3, for Mixed Hyperlipidemia.
Christie M Ballantyne, Szilard Vasas, Masoud Azizad, Peter Clifton, Robert S Rosenson

N Engl J Med· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Randomized, Placebo-Controlled Clinical Trial of Bamlanivimab and Etesevimab Together in High-Risk Ambulatory Patients With COVID-19 and Validation of the Prognostic Value of Persistently High Viral Load.
Michael Dougan, Masoud Azizad, Bharat Mocherla, Robert L Gottlieb, Peter Chen

Clin Infect Dis· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase 2a clinical trial of molnupiravir in patients with COVID-19 shows accelerated SARS-CoV-2 RNA clearance and elimination of infectious virus.
William A Fischer, Joseph J Eron, Wayne Holman, Myron S Cohen, Lei Fang, Masoud M Azizad

Sci Transl Med· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bamlanivimab plus Etesevimab in Mild or Moderate Covid-19.
Michael Dougan, Ajay Nirula, Masoud Azizad, Bharat Mocherla, Robert L Gottlieb

N Engl J Med· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molnupiravir, an Oral Antiviral Treatment for COVID-19.
William Fischer, Joseph J Eron, Wayne Holman, Myron S Cohen, Lei Fang, Masoud M Azizad

medRxiv· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis